← Back
$AVBP All transactions

ArriVent BioPharma, Inc.

M

$ Value

$0

Shares

6,503

Price

$0

Filed

Jul 15

Insider

Name

LaChapelle Robin

Title

Chief Operating Officer

CIK

0002009136

Roles

Officer

Transaction Details

Transaction Date

2025-07-11

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

6,370

Footnotes

The Reporting Person is the Trustee of The MAKS Yao Trust and may be deemed to have shared voting and investment power over the shares held by The MAKS Yao Trust. The Reporting Person does not have a pecuniary interest in and disclaims beneficial ownership of the shares held by The MAKS Yao Trust. | The shares underlying this option vested as to 25% on September 8, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. | The shares underlying this option vested as to 25% on February 1, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.

Filing Info

Accession No.

0001104659-25-067928

Form Type

4

Issuer CIK

0001868279

LaChapelle Robin's History

Date Ticker Type Value
2026-02-02 AVBP A $0
2025-07-11 AVBP M $5K
2025-07-11 AVBP M $6K
2025-07-11 AVBP M $15K
2025-07-11 AVBP M $0
2025-07-11 AVBP M $0
2025-07-11 AVBP M $0

Other Insiders at AVBP (90d)

Insider Bought Sold Last
Yao Zhengbin
President and CEO
2026-02-02
HILLHOUSE INVESTMENT MANAGEMENT, LTD. $13.0M 2025-12-10
Kung Winston
Chief Financial Officer
2026-02-02
Kastenmayer James Paul
General Counsel
2026-02-02
LaChapelle Robin
Chief Operating Officer
2026-02-02
Lutzker Stuart
President of R&D
2026-02-02